Tag: innovative therapies

Myovant Sciences Ltd. Announces Pricing of $75.0 Million Public Offering of Common Shares

BASEL, Switzerland, July 12, 2018 -- Myovant Sciences Ltd. (NYSE: MYOV) ("Myovant"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of...
spot_imgspot_img

Subscribe

Popular articles